BRK x EGFR x Eph x RET x SRC family x VEGFR x Tie-2 - 药物、适应症、专利

Precision Medicine Applied to Locally Advanced Thyroid Cancer Using Tumor-derived Organoids and In-vitro Sensitivity Testing: a Phase 2a, Single-center, Open-label, and Non-comparative Study

The current study aims to explore the potential advantages of anti-cancer therapy that is implemented based on drug sensitivity testing. This pertains to individuals with locally advanced thyroid cancer who have undergone conventional therapy in the past or unresectable patients .

开始日期2021-06-01

申办/合作机构

四川大学华西医院（四川省国际医院）

100 项与 BRK x EGFR x Eph x RET x SRC family x VEGFR x Tie-2 相关的临床结果

登录后查看更多信息

100 项与 BRK x EGFR x Eph x RET x SRC family x VEGFR x Tie-2 相关的转化医学

登录后查看更多信息

0 项与 BRK x EGFR x Eph x RET x SRC family x VEGFR x Tie-2 相关的专利（医药）

登录后查看更多信息

分析

对领域进行一次全面的分析。

登录

或

查看完整样例数据